ARE vs FRT

The deterministic health scores paint a deeply concerning picture, with a Piotroski F-Score of just 2/9 indicating severe financial weakness. Despite a high dividend yield of 8.06%, the payout ratio of 689.47% is unsustainable, and earnings have collapsed, reflected in a negative forward P/E of -746.12 and a YoY EPS decline of -258.6%. While the Price/Book of 0.61 suggests potential value, persistent revenue declines, deteriorating profitability, and a bearish technical trend (0/100) signal significant underlying distress. The lack of analyst price targets and insider buying further undermines confidence in a near-term turnaround.

FRT exhibits strong operational health with a Piotroski F-Score of 7/9, indicating a robust financial foundation. While the stock trades significantly above its Graham Number ($61.34), it remains below its growth-based intrinsic value of $137.76. However, the outlook is tempered by a dangerously high dividend payout ratio of 95.3% and a severely bearish technical trend (10/100). The synthesis of explosive earnings growth and poor technical momentum suggests a period of consolidation or potential correction despite fundamental strength.